ACADIA PHARMACEUTICALS INC Annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from 2017 to 2019

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Acadia Pharmaceuticals Inc quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from 2017 to 2019.
  • Acadia Pharmaceuticals Inc Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending September 30, 2024 was 0.21 pure, unchanged year-over-year.
  • Acadia Pharmaceuticals Inc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2019 was 0.21 pure, unchanged from 2018.
  • Acadia Pharmaceuticals Inc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2018 was 0.21 pure, a 40% decline from 2017.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2019 0.21 0 0% Jan 1, 2019 Dec 31, 2019 10-K 2020-02-27
2018 0.21 -0.14 -40% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 0.35 Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.